| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A pathway to developing and testing quality measures aimed at improving adult vaccination rates in the United States
|
Shen, Angela K.
|
|
2019
|
37 |
10 |
p. 1277-1283
|
article
|
| 2 |
A population-based study of maternal and infant factors influencing influenza vaccination among young children born in Colorado from 2008 to 2016
|
Rao, Suchitra
|
|
2019
|
37 |
10 |
p. 1293-1298
|
article
|
| 3 |
Corrigendum to ‘A report on the status of vaccination in Europe’ [Vaccine 36 (2018) 4979–4992]
|
Sheikh, Shazia
|
|
2019
|
37 |
10 |
p. 1374-1376
|
article
|
| 4 |
Cross-protective Salmonella vaccine reduces cecal and splenic colonization of multidrug-resistant Salmonella enterica serovar Heidelberg
|
Bearson, Shawn M.D.
|
|
2019
|
37 |
10 |
p. 1255-1259
|
article
|
| 5 |
Editorial Board/Aims and Scope
|
|
|
2019
|
37 |
10 |
p. IFC
|
article
|
| 6 |
Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial
|
Borgey, France
|
|
2019
|
37 |
10 |
p. 1260-1265
|
article
|
| 7 |
Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial
|
Wildes, Tyler J.
|
|
2019
|
37 |
10 |
p. 1313-1324
|
article
|
| 8 |
Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population
|
Petrie, Joshua G.
|
|
2019
|
37 |
10 |
p. 1284-1292
|
article
|
| 9 |
Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens
|
Ghorbani, Amir
|
|
2019
|
37 |
10 |
p. 1356-1364
|
article
|
| 10 |
Multi-antigenic recombinant subunit vaccine against Lawsonia intracellularis: The etiological agent of porcine proliferative enteropathy
|
Montesino, R.
|
|
2019
|
37 |
10 |
p. 1340-1349
|
article
|
| 11 |
Needle-free delivery of influenza vaccine using the Med-Jet® H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial
|
Shapiro, Janna R.
|
|
2019
|
37 |
10 |
p. 1332-1339
|
article
|
| 12 |
Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention
|
Dempsey, A.F.
|
|
2019
|
37 |
10 |
p. 1307-1312
|
article
|
| 13 |
Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland
|
Polkowska, Aleksandra
|
|
2019
|
37 |
10 |
p. 1365-1373
|
article
|
| 14 |
Serum antibody immunoreactivity and safety of native porcine and recombinant zona pellucida vaccines formulated with a non-Freund’s adjuvant in horses
|
Nolan, Margaret B.
|
|
2019
|
37 |
10 |
p. 1299-1306
|
article
|
| 15 |
The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax®23) in a healthy adult population and patients diagnosed with primary immunodeficiencies
|
Parker, Antony R
|
|
2019
|
37 |
10 |
p. 1350-1355
|
article
|
| 16 |
Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule
|
Xu, Stanley
|
|
2019
|
37 |
10 |
p. 1325-1331
|
article
|
| 17 |
Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes
|
Roy, S.
|
|
2019
|
37 |
10 |
p. 1266-1276
|
article
|
Journal description